Analyst & Firm | Company | Rating | Price Target |
|---|---|---|---|
Ally Financial | Buy | $50 | |
SPX | Buy | $220 | |
Opus Genetics | Buy | $17 | |
vTv Therapeutics | Buy | $60 | |
Evertec | Buy | $38 | |
Microsoft | Buy | ― | |
Benitec Biopharma | Buy | $17 | |
Liberty Media Liberty Formula One | Buy | $115 | |
Pasithea Therapeutics Corp | Buy | $3 |
Analyst & Firm | Company | Rating | Price Target |
|---|---|---|---|
Ally Financial | Buy | $50 | |
SPX | Buy | $220 | |
Opus Genetics | Buy | $17 | |
vTv Therapeutics | Buy | $60 | |
Evertec | Buy | $38 | |
Microsoft | Buy | ― | |
Benitec Biopharma | Buy | $17 | |
Liberty Media Liberty Formula One | Buy | $115 | |
Pasithea Therapeutics Corp | Buy | $3 |